TowerBrook acquires Clariant unit

The London and New York-based private equity firm has acquired Clariant’s pharmaceuticals fine chemicals business for €70m.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this